Paroxysmal Supraventricular Tachycardia Clinical Trials

24 clinical trials for Paroxysmal Supraventricular Tachycardia across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) — RECRUITING · PHASE2
• NASVAL-SVT: Nasal Swab Versus Modified Valsalva for Supraventricular Tachycardia — RECRUITING · NA
• Outcomes of PFA Vs. RFA for Patients with PSVT: a Retrospective and Propensity Score Matching Study — RECRUITING
• MULTI-CENTER, MULTI-NATIONAL, OPEN-LABEL, EFFICACY AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY IN PEDIATRIC PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA — RECRUITING
• MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY, AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY FOR THE TERMINATION OF SPONTANEOUS EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND TRIAL OF 12 MG VERSUS 6 MG INTRAVENOUS ADENOSINE FOR THE TERMINATION OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA — NOT_YET_RECRUITING
• Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia — COMPLETED · PHASE3
• Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function — NOT_YET_RECRUITING · NA
• A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia — COMPLETED · NA
• Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia — COMPLETED · PHASE3
• Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 — TERMINATED · PHASE3
• MCG for Localization of Tachyarrhythmia's Origin — OTHER · NA
• Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). — TERMINATED · PHASE3
• Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 — COMPLETED · PHASE3
• Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia（PSVT） — COMPLETED · NA
• Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia — COMPLETED · NA
• Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes — COMPLETED · NA
• AN OPEN LABEL EXTENSION STUDY OF ETRIPAMIL NASAL SPRAY IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA — COMPLETED
• Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm — COMPLETED · PHASE2
• The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry. — TERMINATED
• Study on Left Atrial Function of Paroxysmal Supraventricular Tachycardia After Radiofrequency Ablation — COMPLETED · NA
• MULTI-CENTRE, MULTI-NATIONAL, OPEN LABEL, SAFETY STUDY OF ETRIPAMIL NASAL SPRAY FOR PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA — COMPLETED
• MULTI-CENTRE, OPEN-LABEL, SAFETY STUDY OF ETRIPAMIL NASAL SPRAY IN SPONTANEOUS EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA — COMPLETED
• Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control — COMPLETED · PHASE4

Refine this search